Table of Contents China Neurotherapeutic Drugs Market Report 2012-2023 1 Neurotherapeutic Drugs Overview 1.1 Product Overview and Scope of Neurotherapeutic Drugs 1.2 Classification of Neurotherapeutic Drugs by Product Category 1.2.1 China Neurotherapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 China Neurotherapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Peripheral Nervous System Disorders (PNS) Disorder 1.2.4 Autonomous Nervous System (ANS) Disorder 1.2.5 Central Nervous System (CNS) Disorders 1.2.6 Other 1.3 China Neurotherapeutic Drugs Market by Application/End Users 1.3.1 China Neurotherapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Hosptical 1.3.3 Drug Stores 1.3.4 Other 1.4 China Neurotherapeutic Drugs Market by Region 1.4.1 China Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 South China Status and Prospect (2012-2023) 1.4.3 East China Status and Prospect (2012-2023) 1.4.4 Southwest China Status and Prospect (2012-2023) 1.4.5 Northeast China Status and Prospect (2012-2023) 1.4.6 North China Status and Prospect (2012-2023) 1.4.7 Central China Status and Prospect (2012-2023) 1.4.8 Northwest China Status and Prospect (2012-2023) 1.5 China Sales and Revenue ofSales and Revenue of Neurotherapeutic Drugs (2012-2023) 1.5.1 China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Neurotherapeutic Drugs 2.2 Raw Material Analysis of Neurotherapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Neurotherapeutic Drugs 2.4 Other Costs Analysis of Neurotherapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs 2.6 Manufacturing Process Analysis of Neurotherapeutic Drugs 2.7 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 China Neurotherapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.2 BD 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 BD Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 BD Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis AG 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis AG Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Novartis AG Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Johnson & Johnson 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Johnson & Johnson Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Johnson & Johnson Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Pfizer 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pfizer Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pfizer Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Sanofi-Aventis 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sanofi-Aventis Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sanofi-Aventis Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Biogen 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biogen Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biogen Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 GlaxoSmithKline Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 GlaxoSmithKline Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.9 AstraZeneca 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 AstraZeneca Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 AstraZeneca Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 AstraZeneca Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Merck 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Merck Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Merck Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 4 China Neurotherapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 China Neurotherapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 China Neurotherapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 China Neurotherapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 China Neurotherapeutic Drugs Sales and Revenue by Type 4.2.1 China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 China Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 China Neurotherapeutic Drugs Sales and Revenue by Application 4.3.1 China Neurotherapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 China Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 China Neurotherapeutic Drugs Sales (K Units) by Application 5 South China Neurotherapeutic Drugs (Sales, Revenue and Price) 5.1 South China Neurotherapeutic Drugs Sales and Value (2012-2017) 5.1.1 South China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 South China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 South China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 South China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 5.3 South China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 6 East China Neurotherapeutic Drugs (Sales, Revenue and Price) 6.1 East China Neurotherapeutic Drugs Sales and Value (2012-2017) 6.1.1 East China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 East China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 East China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 East China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 6.3 East China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 7 Southwest China Neurotherapeutic Drugs (Sales, Revenue and Price) 7.1 Southwest China Neurotherapeutic Drugs Sales and Value (2012-2017) 7.1.1 Southwest China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 Southwest China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 Southwest China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 Southwest China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 7.3 Southwest China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 8 Northeast China Neurotherapeutic Drugs (Sales, Revenue and Price) 8.1 Northeast China Neurotherapeutic Drugs Sales and Value (2012-2017) 8.1.1 Northeast China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Northeast China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Northeast China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Northeast China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 8.3 Northeast China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 9 North China Neurotherapeutic Drugs (Sales, Revenue and Price) 9.1 North China Neurotherapeutic Drugs Sales and Value (2012-2017) 9.1.1 North China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 North China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 9.1.3 North China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 North China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 9.3 North China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 10 Central China Neurotherapeutic Drugs (Sales, Revenue and Price) 10.1 Central China Neurotherapeutic Drugs Sales and Value (2012-2017) 10.1.1 Central China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Central China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Central China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Central China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 10.3 Central China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 11 Northwest China Neurotherapeutic Drugs (Sales, Revenue and Price) 11.1 Northwest China Neurotherapeutic Drugs Sales and Value (2012-2017) 11.1.1 Northwest China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Northwest China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Northwest China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Northwest China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 11.3 Northwest China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 China Neurotherapeutic Drugs Market Forecast (2018-2023) 13.1 China Neurotherapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 China Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 China Neurotherapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 China Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) 13.2 China Neurotherapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 China Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 China Neurotherapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 South China Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 East China Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Southwest China Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Northeast China Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 Southwest China Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Central China Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Northwest China Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 China Neurotherapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 China Neurotherapeutic Drugs Sales Forecast by Type (2018-2023) 13.3.2 China Neurotherapeutic Drugs Revenue Forecast by Type (2018-2023) 13.3.3 China Neurotherapeutic Drugs Price Forecast by Type (2018-2023) 13.4 China Neurotherapeutic Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure China Market Size (Million USD) Comparison 2012-2023 Table China Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table China Neurotherapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table China Neurotherapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Neurotherapeutic Drugs Table China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure China Neurotherapeutic Drugs Sales (K Units) Market Share by Types in 2017 Figure Peripheral Nervous System Disorders (PNS) Disorder Picture Figure Autonomous Nervous System (ANS) Disorder Picture Figure Central Nervous System (CNS) Disorders Picture Table China Neurotherapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure China Sales Market Share of Neurotherapeutic Drugs by Applications in 2017 Figure Hosptical Picture Figure Drug Stores Picture Figure Other Picture Table China Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure South China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure East China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southwest China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Northeast China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure North China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Central China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Northwest China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Neurotherapeutic Drugs Table Industry News List of Neurotherapeutic Drugs Figure Industry Chain Structure of Neurotherapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Neurotherapeutic Drugs Table Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers China Table Major Buyers of Neurotherapeutic Drugs Table Abbott Basic Information List Table Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Other and Its Application Share Table BD Basic Information List Table BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure BD Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure BD Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure BD Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table BD Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table BD Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table BD Neurotherapeutic Drugs Volume in Other and Its Application Share Table Novartis AG Basic Information List Table Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis AG Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Other and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Other and Its Application Share Table Pfizer Basic Information List Table Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Other and Its Application Share Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Other and Its Application Share Table Biogen Basic Information List Table Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biogen Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Other and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Other and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in Other and Its Application Share Table Company Merck Basic Information List Table Company Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Merck Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Merck Neurotherapeutic Drugs Sales China Market Share (%) (2012-2017) Figure Company Merck Neurotherapeutic Drugs Revenue China Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Merck Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Company Merck Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Company Merck Neurotherapeutic Drugs Volume in Other and Its Application Share Table China Neurotherapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table China Neurotherapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 China Neurotherapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 China Neurotherapeutic Drugs Sales Share by Players/Manufacturers Table China Neurotherapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table China Neurotherapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 China Neurotherapeutic Drugs Revenue Market Share (%) Players Figure 2017 China Neurotherapeutic Drugs Revenue Market Share (%) Players Table China Neurotherapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table China Neurotherapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Neurotherapeutic Drugs by Type (2012-2017) Figure China Neurotherapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table China Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table China Neurotherapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Neurotherapeutic Drugs by Type (2012-2017) Figure China Neurotherapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table China Neurotherapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table China Neurotherapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Neurotherapeutic Drugs by Regions (2012-2017) Figure China Neurotherapeutic Drugs Sales Market Share by Regions in 2017 Table China Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table China Neurotherapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Neurotherapeutic Drugs by Regions (2012-2017) Figure China Neurotherapeutic Drugs Revenue Market Share by Regions in 2017 Table China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table China Neurotherapeutic Drugs Sales Share (%) by Application (2012-2017) Figure China Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) Figure China Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) Figure South China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure South China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table South China Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South China Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table South China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table South China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure East China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure East China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure East China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table East China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table East China Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure East China Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table East China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table East China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure East China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Southwest China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southwest China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southwest China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Southwest China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Southwest China Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Southwest China Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Southwest China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Southwest China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Southwest China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Northeast China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Northeast China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northeast China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Northeast China Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northeast China Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Northeast China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Northeast China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Central China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Central China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Central China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Central China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Central China Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Central China Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Central China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Central China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Central China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure North China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure North China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure North China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table North China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table North China Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure North China Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table North China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table North China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure North China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Northwest China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Northwest China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northwest China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northwest China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Northwest China Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northwest China Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Northwest China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Northwest China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northwest China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure China Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) Table China Neurotherapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure China Neurotherapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure China Neurotherapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table China Neurotherapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure China Neurotherapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure China Neurotherapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure South China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure East China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure East China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure North China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Central China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Central China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table China Neurotherapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure China Neurotherapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table China Neurotherapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure China Neurotherapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table China Neurotherapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table China Neurotherapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure China Neurotherapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott BD Novartis AG Johnson & Johnson Pfizer Sanofi-Aventis Biogen GlaxoSmithKline AstraZeneca Merck